Edmund Lee

Company: Regulus Therapeutics

Job title: Executive Director, Biology

Seminars:

Targeting miR-17 to Address the Genetic Cause of ADPKD 4:30 pm

Advancing biomarker translational research in PKD to elucidate therapeutic efficacy Addressing root causes of ADPKD with anti-miRs Clinical development of 2nd generation inhibitor RGLS8429Read more

day: Day Two